Pharmaceuticals Supplements Medical Devices
About Us Careers FAQ All Insights
Privacy Policy Terms of Service
Thai FDA Drug Registration Local Authorized Representative (LAR) & Importer of Record (IOR) Dossier Preparation, ACTD Submissions & Thai Labeling GMP Compliance Consulting Post-Approval Lifecycle Management Pharmacovigilance Government Fee Schedule Pharmaceutical Insights
Thai FDA Supplement Registration Local Importer & Orr.7 Import License GMP Requirements for Supplement Manufacturers Labeling & Health Claims Ingredient Approval & Novel Food Advertising Approval & the Kho Or Permit Supplement Insights
Thai FDA Medical Device Registration Device Classification: AMDD Classes 1-4 Local License Holder & Establishment Licensing Technical File & CSDT Preparation Labeling Requirements: B.E. 2568 (2025) Medical Device Insights
Email WhatsApp (+66) 082.208.2460
Email WhatsApp (+66) 082.208.2460

Supplement Import Documentation Requirements in Thailand

Every supplement shipment imported into Thailand must pass port health inspection before Thai customs clearance. The required documents include the product registration certificate, a health certificate from the country of export, a batch Certificate of Analysis, and GMP documentation for the manufacturer. Incomplete documentation results in shipment holds that can last weeks.

Import documentation overview

Supplement imports into Thailand are cleared through Thai FDA's Port Health Division at the port of entry. The port health officer inspects the shipment documentation and may physically sample the goods for testing before clearance is granted. The document set required for each supplement shipment is defined by Thai FDA's import control notifications and the specific conditions attached to the product's registration certificate.

The port health clearance process is separate from Thai Customs clearance. Both must be completed before goods can be released to the importer's warehouse. Thai FDA port health and Thai Customs can operate on different timelines, and delays with either authority can hold the shipment. The supplement importer must ensure that both the Thai FDA port health documentation and the standard commercial import documents (commercial invoice, packing list, bill of lading or airway bill) are complete and consistent before the shipment arrives.

Inconsistencies between documents, even minor ones such as slight differences in product name spelling between the registration certificate and the health certificate, are treated as a deficiency and will result in the shipment being held for clarification. Developing a standard document review checklist, reviewed before each shipment departs the country of origin, is one of the most effective ways to avoid import delays.

Required documents for each shipment

Label inspection at the border

Thai FDA port health officers physically inspect product labels on sampled units to verify that the Thai-language label on the product matches the approved label registered with Thai FDA. Any deviation from the approved label, including changes to the Thai-language text, the list of ingredients, the nutritional content values, or the storage and use instructions, will result in the shipment being held and may require a label variation application before the goods can be released.

Common label issues that cause import holds include: label updates made by the manufacturer without notifying the Thai importer; Thai-language label printing errors that differ from the approved Thai label file; and physical label application that leaves the Thai label incorrectly positioned or partially obscuring required information on the original label. The Thai importer's quality team should inspect label samples from each production batch before shipment to verify that the applied Thai label matches the approved version.

Sampling and testing at import

Thai FDA port health officers may collect samples from supplement shipments for testing by the Thai FDA laboratory before the goods are released. The frequency of sampling is risk-based: products with a history of compliance, from well-established manufacturers and with complete documentation, are sampled less frequently than new products, products from manufacturers with prior compliance issues, or product categories under enhanced surveillance.

When samples are collected, the goods may be held pending the test results, or may be conditionally released to a bonded warehouse while testing is completed, depending on the risk profile and the discretion of the port health officer. The testing period typically takes 5 to 15 working days depending on the parameters being tested. If the results are compliant, the goods are released. If a non-compliance is identified, the importer is notified and the goods may be seized, re-exported, or destroyed.

Importers should maintain a buffer inventory in Thailand sufficient to cover the maximum potential import delay, including the possibility of sampling and testing. A business that operates on just-in-time inventory with no buffer stock is highly exposed to supply disruptions from any import hold, whether for documentation issues or sample testing.

The Vero Approach

VeroPharma Group supports supplement clients through the import clearance process for every shipment, including document preparation checklists, pre-shipment document review, and coordination with the port health officer when shipments are sampled or held. A shipment hold that is managed well, with immediate response to Thai FDA queries and complete documentation supplied promptly, typically resolves faster than one left for the shipper or freight forwarder to handle.

For new supplement importers in Thailand, we conduct a pre-first-shipment documentation audit to identify any document format or content issues before the first shipment arrives, rather than discovering them at the border.